E. Samantas

Thalidomide and dexamethasone combination for refractory multiple myeloma

Meletios Α. Dimopoulos, Konstantinos Zervas, G. Kouvatseas et al. · Annals of Oncology · 2001 · 282 citations · Full text

Medicine, Hematology, Oncology +13

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

George Fountzilas, E. Ciuleanu, Mattheos Bobos et al. · Annals of Oncology · 2011 · 248 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Aristotelis Bamias, Gerasimos Aravantinos, C. Deliveliotis et al. · Journal of Clinical Oncology · 2003 · 188 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial

P. Kosmidis, N. Mylonakis, Dimosthenis Skarlos et al. · Annals of Oncology · 2000 · 74 citations · Full text

Medicine, Oncology, Pharmacology +12

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group

P. Kosmidis, Haralabos P. Kalofonos, C. Christodoulou et al. · Annals of Oncology · 2007 · 52 citations

Medicine, Oncology, Pharmacology +9